TransMedics (TMDX) Change in Accured Expenses (2018 - 2026)

TransMedics has reported Change in Accured Expenses for 9 years, with the latest figure at -$3.1 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Accured Expenses rose 33.14% year-over-year to -$3.1 million; the trailing twelve-month figure through Mar 2026 stood at $19.2 million (up 475.32% YoY), and the FY2025 full-year result was $17.7 million, up 122.9% from the prior year.
• Change in Accured Expenses for Q1 2026 stood at -$3.1 million, down from $7.0 million in the prior quarter.
• The five-year high for Change in Accured Expenses was $13.1 million in Q3 2025, with the low at -$4.6 million in Q1 2025.
• Average Change in Accured Expenses over 5 years is $2.4 million, with a median of $2.2 million recorded in 2025.
• Year-over-year, Change in Accured Expenses surged 86450.0% in 2023 and slumped 9377.55% in 2025.
• Tracing TMDX's Change in Accured Expenses over 5 years: stood at $3.4 million in 2022, then soared by 44.93% to $5.0 million in 2023, then sank by 53.45% to $2.3 million in 2024, then soared by 199.74% to $7.0 million in 2025, then sank by 144.57% to -$3.1 million in 2026.
• The last three Change in Accured Expenses figures came in at -$3.1 million (Q1 2026), $7.0 million (Q4 2025), and $13.1 million (Q3 2025), per Business Quant data.

Peer Comparison